ICUI - CIK 0000883984
The table below shows ICU MEDICAL INC/DE's cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | $179.85M | $204.03M | $166.20M | -$62.13M | $267.54M | $222.75M |
| Capital expenditure | $88.04M | $79.37M | $83.89M | $90.31M | $68.54M | $92.00M |
| Investing cash flow | $122.23M | -$88.96M | -$87.95M | -$1.91B | -$90.69M | -$98.14M |
| Dividends paid | - | - | - | - | - |
ICU MEDICAL INC/DE reported operating cash flow of $179.85M for fiscal year 2025. That is down 11.9% from $204.03M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from $89.94M (FY 2016) to $179.85M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| Stock buybacks | $8.77M | $11.99M | $9.35M | $10.88M | $8.34M | $12.88M |
| Financing cash flow | -$311.52M | -$55.80M | -$35.98M | $1.64B | -$16.87M | -$40.00K |